NASDAQ:TCRX | Income Statement | TScan Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$1.05M$23.4M$31.54M-$30.49M-$30.36M-$0.23-$0.23129,948,878129,948,878
2026-03-31$982,000.00$21.9M$30.12M-$29.14M-$28.67M-$0.22-$0.22129,913,376129,913,376
2025-12-31$2.57M$20.04M$26.43M-$23.86M-$22.98M-$0.18-$0.1828,51828,518
2025-09-30$2.51M$31.69M$39.56M-$37.05M-$35.71M-$0.28-$0.28129,835,938129,835,938
2025-06-30$3.08M$32.63M$41.73M-$38.65M-$36.95M-$0.28-$0.28129,730,451129,730,451
2025-03-31$2.17M$29.79M$38.42M-$36.25M-$34.13M-$0.26-$0.26129,678,572129,678,572
2024-12-31$665,000.00$29.35M$37.38M-$36.71M-$35.81M-$0.30-$0.302,954,4792,954,479
2024-09-30$1.05M$26.26M$33.67M-$32.62M-$29.89M-$0.25-$0.25118,700,362118,700,362
2024-06-30$536,000.00$26.88M$34.65M-$34.11M-$31.66M-$0.28-$0.28113,425,357113,425,357
2024-03-31$566,000.00$24.86M$31.94M-$31.37M-$30.14M-$0.32-$0.3294,875,89394,875,893
2023-12-31$7.21M$22.41M$28.57M-$21.36M-$19.61M-$0.11-$0.119,888,6069,888,606
2023-09-30$3.89M$22.74M$28.64M-$24.75M-$23M-$0.24-$0.2494,829,84494,829,844
2023-06-30$3.15M$21.23M$27.76M-$24.61M-$24.05M-$0.51-$0.5147,208,66447,208,664
2023-03-31$6.8M$21.78M$29.55M-$22.74M-$22.56M-$0.93-$0.9324,225,95424,225,954
2022-12-31$3.1M$15.6M$21.74M-$18.65M-$18.72M-$0.77-$0.7710,01010,010
2022-09-30$3.36M$15.03M$19.94M-$16.58M-$16.25M-$0.67-$0.6724,073,93524,073,935
2022-06-30$4.06M$14.49M$19.3M-$15.25M-$15.1M-$0.63-$0.6324,063,67724,063,677
2022-03-31$3.02M$14.69M$19.18M-$16.16M-$16.16M-$0.67-$0.6723,974,64223,974,642
2021-12-31$2.85M$12.61M$17.06M-$14.2M-$14.2M$0.38$0.384,100,2364,100,236
2021-09-30$2.41M$14.21M$18.25M-$15.84M-$15.84M-$0.80-$0.8019,875,42819,875,428
2021-06-30$2.85M$10.8M$13.53M-$10.68M-$10.67M-$7.69-$7.691,387,9731,387,973
2021-03-31$2.03M$7.34M$9.95M-$7.92M-$7.91M1,218,909
2020-12-31$795,000.00$5.96M$8.61M-$7.81M-$7.81M19,914
2020-09-30$290,000.00$5.81M$7.46M-$7.17M-$7.17M1,001,853
2020-06-30$4.5M$5.62M-$5.62M-$5.61M908,564

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$10.33M$114.15M$146.14M-$135.81M$0.00-$129.77M-$1.00-$1.00129,777,415129,777,415
2024-12-31$2.82M$107.35M$137.64M-$134.82M-$127.5M-$1.14-$1.14111,990,417111,990,417
2023-12-31$21.05M$88.15M$114.51M-$93.46M-$89.22M-$1.36-$1.3665,599,85865,599,858
2022-12-31$13.54M$59.82M$80.17M-$66.64M-$66.22M-$2.75-$2.7524,048,26724,048,267
2021-12-31$10.14M$44.95M$58.78M-$48.64M-$48.63M-$4.17-$4.1711,662,67211,662,672
2020-12-31$1.09M$20.58M$27.32M-$26.23M-$26.13M916,014

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.